Clinical Trials Directory

Trials / Completed

CompletedNCT00315263

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

Genomics, SNPs, and Clinical Neonatology

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
Children's Mercy Hospital Kansas City · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).

Detailed description

This genetic predisposition study does not involve investigational drugs, devices, or treatments. Our broad goal is to identify genomic factors, which contribute to the development or exacerbation of common and critical illnesses that affect preterm and near-term infants. We seek to accomplish this goal in the following ways: * First: to test candidate gene DNA variations and link already identified single nucleotide polymorphisms (SNPs) producing functional alterations to the risk of clinically important disorders. * Second: to utilize a whole-genomic approach to identify SNPs not previously linked to the risk of development or progression of neonatal disorders.

Conditions

Timeline

Start date
2006-04-01
Primary completion
2008-10-01
Completion
2011-07-01
First posted
2006-04-18
Last updated
2011-08-26

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00315263. Inclusion in this directory is not an endorsement.